The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 4.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 68%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (6 analysts) rates it buy, with a mean price target of $984.
Emcor
EME · a US exchange · USD · Market cap $28.3B · 44,000 employees
EMCOR Group, Inc.
FAIL · Does not pass the screenPrice as of 13 Nov 2026Daily close, not a live quote
Screened 2026-11-13 · the tape above runs as of 06:12 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price659.36 USD at the 13 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 13 Nov 2026
- Our regime readDistribution, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans to puts (put/call 1.43)
- Last reviewed13 Nov 2026 (3 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $621.00 to $1,022.66, base estimate $868.07 (screen dated 2026-11-13).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 1.43, read 2026-11-15
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
Emcor holds its Distribution at $659.36. Consolidating, no directional conviction, held for 7 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 7 days |
| Price at the screen | $659.36 |
| Valuation | 18.66 trailing · 15.78 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 1.16 |
Five Screens, Shown in Full
Does not pass. Accounts receivable
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 5.04% | Below 33% | Interest-bearing debt is just 5.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 57.61% | Below 49% | Money owed to the company is 57.6% of assets, above the 49% limit. | Fail |
| Revenue purity | 0.12% | Below 5% | Only 0.1% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Emcor's business is fine, but its receivables are about 58% of its assets, just over the ~49% line, so it does not pass on the financial screens.
Read as at 2026-11-14. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when EME's ethical verdict changes
Today EME does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 13 Nov 2026: it trades at roughly a 24% discount to our $868.07 fair value, narrow competitive moat, 28.80% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. A 24.0% discount to the base estimate.
Third-party analyst targets: 9 covering, consensus Buy. The average target sits +39% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $868.07, with a range of $621.00 to $1,022.66, dated to the 2026-11-13 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it stands out
A 29%-growth business trading at just 15.8x forward earnings, with a narrow competitive moat and minimal debt. That is a 24% discount to our $868.07 fair value: the market is pricing it cautiously while the fundamentals argue otherwise. 9 analysts rate it Buy with a $918.00 average target, about 39% above the screened price.
| Forward P/E | 15.8xcheap for a company growing this fast |
| Trailing P/E | 18.7xreasonably valued |
| EPS, trailing | 34.59 |
| EPS, forward | 40.91 |
| Revenue growth | +28.8%strong top-line growth |
| Profit margin | 7.8%thin but positive margins |
| Return on equity | 40.6%an exceptional return on shareholder capital |
| FCF yield | 4.55% |
| Dividend yield | 0.15% |
| Debt to equity | 0.13minimal debt: a conservative balance sheet |
| Current ratio | 1.17adequate liquidity, worth monitoring |
| Beta | 1.16moves a little more than the market |
| Short interest, float | 0.02% |
| 52-week range | 564.92 - 951.96 |
| Moat | NARROW |
| Market cap | $28.3B |
| Employees | 44,000 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeEME trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 1.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 68%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (6 analysts) rates it buy, with a mean price target of $984.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 11.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 68%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (6 analysts) rates it buy, with a mean price target of $984. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 68%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (6 analysts) rates it buy, with a mean price target of $984. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 68%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (6 analysts) rates it buy, with a mean price target of $984. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 68%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (6 analysts) rates it buy, with a mean price target of $984. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 68%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (6 analysts) rates it buy, with a mean price target of $984. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 68%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (6 analysts) rates it buy, with a mean price target of $984. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 68%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (6 analysts) rates it buy, with a mean price target of $984. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 68%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (6 analysts) rates it buy, with a mean price target of $984. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Comfort Systems Plunges 26.8% in a Month: Time to Buy FIX Stock? Yahoo Finance · 3d ago
- EMCOR Group, Inc. Announces Agreement to Acquire P1 Construction, LLC Yahoo Finance · 3d ago
- Investors Heavily Search EMCOR Group, Inc. (EME): Here is What You Need to Know Yahoo Finance · 3d ago
- Will Dycom's Data Center Growth Face Local Pushback and Delays? Yahoo Finance · 4d ago
- EMCOR Stock Plunges 17% in a Month: Buy the Low Now or Wait? Yahoo Finance · 5d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-17 | McEvoy M Kevin | Dir | P - Purchase | 3 | $2,300 |
| 2026-05-11 | REID WILLIAM P | Director | 2,000 | $1,851,560 | |
| 2026-05-01 | ALTMEYER JOHN W | Director | 2,500 | $2,237,500 | |
| 2026-04-30 | REID WILLIAM P | Director | 1 | · | |
| 2026-04-30 | ALTMEYER JOHN W | Director | 2 | · | |
| 2026-04-30 | MAURICIO MAXINE LUM | General Counsel | 4 | · | |
| 2026-04-30 | NALBANDIAN JASON R. | Chief Financial Officer | 4 | · | |
| 2026-04-30 | GUZZI ANTHONY J | Chief Executive Officer | 13 | · | |
| 2026-04-30 | GUZZI ANTHONY J | Chief Executive Officer | 3,000 | · | |
| 2026-04-30 | SCHWARZWAELDER STEVEN | Director | 5,602 | $5,014,854 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-10-07 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-10-07 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-09-25 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-09-25 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-09-25 | Ro Khanna | Democrat | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $931.50 | -16.1% | · | $839 | -16.1% |
| 2 months | $802.03 | -2.5% | $0.40 | $975 | -2.5% |
| 3 months | $710.18 | +10.1% | $0.40 | $1,101 | +10.1% |
| 6 months | $638.88 | +22.4% | $0.80 | $1,225 | +22.5% |
| 1 year | $465.04 | +68.1% | $1.30 | $1,684 | +68.4% |
| 2 years | $377.41 | +107.1% | $2.30 | $2,077 | +107.7% |
| 3 years | $173.26 | +351.2% | $3.09 | $4,529 | +352.9% |
| 5 years | $124.63 | +527.2% | $4.22 | $6,306 | +530.6% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever EME does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.